Amikacin Sulfate injection USP recall: Particulate Matter
Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceuticals USA, INC. North Wales, PA…
Why was Amikacin Sulfate injection USP recalled?
Presence of Particulate Matter: particulate matter identified as glass in one vial.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 4750915, Exp 9/2017
- Product
- Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceuticals USA, INC. North Wales, PA…
- Recalling firm
- Teva Pharmaceuticals USA
- Quantity
- 6,291 units
- Distribution
- Nationwide and Puerto Rico
- Recall date
- June 1, 2016
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)